Highly absorbent antimicrobial alginate dressing
Benefits of Melgisorb Ag • Excellent absorption for heavily exuding deep wounds • Provides sustained antimicrobial effect • High fiber strength allows removal in one piece
Areas of useMelgisorb Ag is indicated for the management of moderate to heavily exuding partial to full thickness wounds such as:• post-operative surgical wounds• trauma wounds (dermal lesions, trauma injuries or incisions)• leg ulcers• pressures ulcers• diabetic ulcers• graft and donor sites• partial thickness burns
This product can also be used under compression bandages. As the product contains alginate, it may assist in supporting the control of minor bleeding in superficial wounds. Melgisorb Ag may be used in the management of infected wounds or wounds in which there is an increased risk of infection under the medical supervision of a healthcare professional. Melgisorb Ag is indicated for external use only. NoteMelgisorb Ag can remain in situ up to 7 days. Dressing change frequency will depend on wound condition and the level of exudate. Initially it may be necessary to change the dressing every 24 hours. If the wound appears dry, saturate the dressing with sterile saline solution prior to removal. Gently remove the dressing from the wound bed. Irrigate the wound site in accordance with standard protocols prior to application of a new dressing. Contra-indicationsMelgisorb Ag is not indicated for use on the following:• individuals with a known sensitivity to alginates or silver• surgical implantation• to control heavy bleeding• for direct application on dry or lightly exuding wounds. Precautions• The dressing may adhere if used on dry or very lightly exuding wounds. If the dressing does adhere and is not easily removed, moisten with sterile saline solution prior to removal.• The dressing performance may be impaired by excess use of petroleum-based ointments.• Avoid contact with electrodes or conductive gels during electronic measurements, e.g. electrocardiograms (ECG) and electroencephalograms (EEG).• The dressing must be removed prior to patients undergoing Magnetic Resonance Imaging (MRI) examinations.• In the event of clinical infection, topical silver does not replace the need for systemic therapy or other adequate infection treatment.
Information will be published shortly.